In comparison to the flood of emergency use authorizations doled out by the FDA throughout the COVID-19 pandemic, the number of those tests and devices that have gone on to receive full, non-pandemic ...

Following its blockbuster buy of medtech manufacturer Hillrom late last year, Baxter may now be preparing to trim some of the fat from its newly expanded product portfolio. The devicemaker is said to ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx ...

Please provide your email address to receive an email when new articles are posted on . Baxter International plans to spin off its renal care and acute therapies global business units into an ...

Baxter International says it's achieved a 25% lower mortality risk for up to four years in hemodialysis patients in a study of its new therapy. In a 48-month study of 1,092 dialysis patients, Baxter's ...

(Bloomberg)–Baxter International Inc. is considering divesting two units within its flagship renal-care business, according to people familiar with the matter, as it looks to refocus following its ...

CHICAGO (AP) -- A lawsuit filed against Baxter International Inc. on Tuesday asks for damages on behalf of patients who used its ``potentially deadly'' dialysis machines, which are blamed in dozens of ...

DEERFIELD, Ill. (AP) — Drug and medical device maker Baxter International plans to buy the privately held Swedish company Gambro AB for about $2.76 billion to broaden its dialysis product portfolio.

Hurricane Helene is gone, but its ripple effects continue all across the U.S., with tens of thousands of dialysis patients now at risk of losing access to lifesaving care due to a shocked supply chain ...